XML 55 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value (Tables)
9 Months Ended
Sep. 30, 2014
Fair Value Disclosures [Abstract]  
Recurring Fair Value Measurements
The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below.
 
September 30, 2014
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$

 
$
100,634

 
$
7,340

 
$
107,974

Foreign corporate

 
55,644

 
6,233

 
61,877

Foreign government

 
55,118

 
1,278

 
56,396

U.S. Treasury and agency
34,150

 
22,712

 

 
56,862

RMBS
1,513

 
35,100

 
4,006

 
40,619

CMBS

 
14,015

 
634

 
14,649

ABS

 
11,574

 
3,279

 
14,853

State and political subdivision

 
14,836

 
4

 
14,840

Total fixed maturity securities
35,663

 
309,633

 
22,774

 
368,070

Equity securities:
 
 
 
 
 
 
 
Common stock
1,606

 
867

 
101

 
2,574

Non-redeemable preferred stock

 
868

 
247

 
1,115

Total equity securities
1,606

 
1,735

 
348

 
3,689

FVO and trading securities:
 
 
 
 
 
 
 
Actively Traded Securities

 
664

 
8

 
672

FVO general account securities
528

 
63

 
99

 
690

FVO contractholder-directed unit-linked investments
11,174

 
4,204

 
488

 
15,866

FVO securities held by CSEs

 
6

 
12

 
18

Total FVO and trading securities
11,702

 
4,937

 
607

 
17,246

Short-term investments (1)
4,066

 
6,483

 
155

 
10,704

Mortgage loans:
 
 
 
 
 
 
 
Residential mortgage loans — FVO

 

 
298

 
298

Commercial mortgage loans held by CSEs — FVO

 
313

 

 
313

Total mortgage loans

 
313

 
298

 
611

Other invested assets:
 
 
 
 
 
 

Other investments
241

 
65

 

 
306

Derivative assets: (2)
 
 
 
 
 
 


Interest rate
4

 
6,770

 
49

 
6,823

Foreign currency exchange rate

 
1,517

 
27

 
1,544

Credit

 
150

 
13

 
163

Equity market
24

 
1,294

 
323

 
1,641

Total derivative assets
28

 
9,731

 
412

 
10,171

Total other invested assets
269

 
9,796

 
412

 
10,477

Net embedded derivatives within asset host contracts (3)

 

 
361

 
361

Separate account assets (4)
87,799

 
229,790

 
1,891

 
319,480

Total assets
$
141,105

 
$
562,687

 
$
26,846

 
$
730,638

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (2)
 
 
 
 
 
 
 
Interest rate
$
5

 
$
1,910

 
$
2

 
$
1,917

Foreign currency exchange rate
2

 
1,402

 
81

 
1,485

Credit

 
35

 
5

 
40

Equity market
5

 
1,050

 
669

 
1,724

Total derivative liabilities
12

 
4,397

 
757

 
5,166

Net embedded derivatives within liability host contracts (3)

 
7

 
(504
)
 
(497
)
Long-term debt of CSEs — FVO

 
171

 
15

 
186

Trading liabilities (5)
118

 
78

 

 
196

Total liabilities
$
130

 
$
4,653

 
$
268

 
$
5,051

 
December 31, 2013
 
Fair Value Hierarchy
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
Fixed maturity securities:
 
 
 
 
 
 
 
U.S. corporate
$

 
$
99,321

 
$
7,148

 
$
106,469

Foreign corporate

 
56,448

 
6,704

 
63,152

Foreign government

 
52,202

 
2,235

 
54,437

U.S. Treasury and agency
25,061

 
20,000

 
62

 
45,123

RMBS

 
32,098

 
2,957

 
35,055

CMBS

 
15,578

 
972

 
16,550

ABS

 
11,361

 
4,210

 
15,571

State and political subdivision

 
13,820

 
10

 
13,830

Total fixed maturity securities
25,061

 
300,828

 
24,298

 
350,187

Equity securities:
 
 
 
 
 
 
 
Common stock
1,186

 
990

 
177

 
2,353

Non-redeemable preferred stock

 
654

 
395

 
1,049

Total equity securities
1,186

 
1,644

 
572

 
3,402

FVO and trading securities:
 
 
 
 
 
 
 
Actively Traded Securities
2

 
648

 
12

 
662

FVO general account securities
518

 
80

 
29

 
627

FVO contractholder-directed unit-linked investments
10,702

 
4,806

 
603

 
16,111

FVO securities held by CSEs

 
23

 

 
23

Total FVO and trading securities
11,222

 
5,557

 
644

 
17,423

Short-term investments (1)
5,915

 
6,943

 
254

 
13,112

Mortgage loans:
 
 
 
 
 
 
 
Residential mortgage loans — FVO

 

 
338

 
338

Commercial mortgage loans held by CSEs — FVO

 
1,598

 

 
1,598

Total mortgage loans

 
1,598

 
338

 
1,936

Other invested assets:
 
 
 
 
 
 
 
Other investments
188

 
71

 

 
259

Derivative assets: (2)
 
 
 
 
 
 
 
Interest rate
10

 
5,557

 
27

 
5,594

Foreign currency exchange rate
1

 
1,280

 
28

 
1,309

Credit

 
144

 
29

 
173

Equity market
1

 
1,233

 
285

 
1,519

Total derivative assets
12

 
8,214

 
369

 
8,595

Total other invested assets
200

 
8,285

 
369

 
8,854

Net embedded derivatives within asset host contracts (3)

 

 
285

 
285

Separate account assets (4)
89,960

 
225,776

 
1,465

 
317,201

Total assets
$
133,544

 
$
550,631

 
$
28,225

 
$
712,400

Liabilities
 
 
 
 
 
 
 
Derivative liabilities: (2)
 
 
 
 
 
 
 
Interest rate
$
9

 
$
2,568

 
$
14

 
$
2,591

Foreign currency exchange rate
1

 
1,971

 
39

 
2,011

Credit

 
52

 

 
52

Equity market
43

 
1,222

 
602

 
1,867

Total derivative liabilities
53

 
5,813

 
655

 
6,521

Net embedded derivatives within liability host contracts (3)

 
4

 
(973
)
 
(969
)
Long-term debt of CSEs — FVO

 
1,427

 
28

 
1,455

Trading liabilities (5)
260

 
2

 

 
262

Total liabilities
$
313

 
$
7,246

 
$
(290
)
 
$
7,269

__________________
(1)
Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.
(2)
Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.
(3)
Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables on the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented within PABs, future policy benefits and other liabilities on the consolidated balance sheets. At September 30, 2014 and December 31, 2013, equity securities also included embedded derivatives of ($176) million and ($145) million, respectively.
(4)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.
(5)
Trading liabilities are presented within other liabilities on the consolidated balance sheets.
Fair Value Inputs, Quantitative Information
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
 
 
 
 
 
 
 
September 30, 2014
 
December 31, 2013
 
Impact of
Increase in Input
on Estimated
Fair Value (2)
 
Valuation
Techniques
 
Significant
Unobservable Inputs
 
Range
 
Weighted
Average (1)
 
Range
 
Weighted
Average (1)
 
Fixed maturity securities (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate and foreign corporate
Matrix pricing
 
Delta spread adjustments (4)
 
(20)
-
250
 
51
 
(10)
-
240
 
46
 
Decrease
 
 
 
 
Illiquidity premium (4)
 
30
-
30
 
30
 
30
-
30
 
30
 
Decrease
 
 
 
 
Credit spreads (4)
 
(1,471)
-
3,117
 
184
 
(1,489)
-
876
 
174
 
Decrease
 
 
 
 
Offered quotes (5)
 
-
121
 
92
 
4
-
145
 
100
 
Increase
 
Market pricing
 
Quoted prices (5)
 
-
750
 
158
 

 

 

 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
31
-
126
 
107
 
33
-
145
 
95
 
Increase
Foreign government
Matrix pricing
 
Credit spreads (4)
 
48
-
48
 
48
 
4
-
72
 
32
 
Decrease
 
Market pricing
 
Quoted prices (5)
 
1
-
163
 
81
 
64
-
156
 
100
 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
66
-
122
 
108
 
84
-
156
 
107
 
Increase
RMBS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
45
-
413
 
225
 
(136)
-
3,609
 
288
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
22
-
120
 
95
 
10
-
109
 
98
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
1
-
116
 
93
 
69
-
101
 
93
 
Increase (6)
CMBS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 



 

 
215
-
2,025
 
409
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
5
-
112
 
101
 
70
-
104
 
97
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
100
-
100
 
100
 
90
-
101
 
95
 
Increase (6)
ABS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
31
-
1,878
 
152
 
30
-
1,878
 
145
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
-
110
 
100
 
-
110
 
101
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
100
-
100
 
100
 
56
-
106
 
98
 
Increase (6)
Derivatives
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
Interest rate
Present value techniques
 
Swap yield (7)
 
324
-
351
 
 
 
248
-
450
 
 
 
Increase (12)
Foreign currency exchange rate
Present value techniques
 
Swap yield (7)
 
(12)
-
1,012
 
 
 
97
-
767
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
43%
-
55%
 
 
 
38%
-
47%
 
 
 
 
Credit
Present value techniques
 
Credit spreads (9)
 
98
-
101
 
 
 
98
-
101
 
 
 
Decrease (9)
 
Consensus pricing
 
Offered quotes (10)
 
 

 
 
 
 
 
 
 
 
 
 
 
Equity market
Present value techniques or option pricing models
 
Volatility (11)
 
14%
-
28%
 
 
 
13%
-
28%
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
65%
-
65%
 
 
 
60%
-
60%
 
 
 
 
Embedded derivatives
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and assumed guaranteed minimum benefits
Option pricing techniques
 
Mortality rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ages 0 - 40
 
0%
-
0.28%
 
 
 
0%
-
0.14%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 41 - 60
 
0.04%
-
0.88%
 
 
 
0.04%
-
0.88%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 61 - 115
 
0.26%
-
100%
 
 
 
0.26%
-
100%
 
 
 
Decrease (13)
 
 
 
 
Lapse rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Durations 1 - 10
 
0.50%
-
100%
 
 
 
0.50%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 11 - 20
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 21 - 116
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
Utilization rates
 
20%
-
50%
 
 
 
20%
-
50%
 
 
 
Increase (15)
 
 
 
 
Withdrawal rates
 
0%
-
20%
 
 
 
0%
-
40%
 
 
 
(16)
 
 
 
 
Long-term equity volatilities
 
7.30%
-
33%
 
 
 
9.14%
-
40%
 
 
 
Increase (17)
 
 
 
 
Nonperformance risk spread
 
(0.16)%
-
0.77%
 
 
 
(1.08)%
-
0.83%
 
 
 
Decrease (18)
______________

(1)
The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
(2)
The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
(3)
Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
(4)
Range and weighted average are presented in basis points.
(5)
Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
(6)
Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
(7)
Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(8)
Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
(9)
Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
(10)
At both September 30, 2014 and December 31, 2013, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
(11)
Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(12)
Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
(13)
Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(14)
Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(15)
The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(16)
The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(17)
Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(18)
Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
Fair Value Inputs, Quantitative Information
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
 
 
 
 
 
 
 
September 30, 2014
 
December 31, 2013
 
Impact of
Increase in Input
on Estimated
Fair Value (2)
 
Valuation
Techniques
 
Significant
Unobservable Inputs
 
Range
 
Weighted
Average (1)
 
Range
 
Weighted
Average (1)
 
Fixed maturity securities (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. corporate and foreign corporate
Matrix pricing
 
Delta spread adjustments (4)
 
(20)
-
250
 
51
 
(10)
-
240
 
46
 
Decrease
 
 
 
 
Illiquidity premium (4)
 
30
-
30
 
30
 
30
-
30
 
30
 
Decrease
 
 
 
 
Credit spreads (4)
 
(1,471)
-
3,117
 
184
 
(1,489)
-
876
 
174
 
Decrease
 
 
 
 
Offered quotes (5)
 
-
121
 
92
 
4
-
145
 
100
 
Increase
 
Market pricing
 
Quoted prices (5)
 
-
750
 
158
 

 

 

 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
31
-
126
 
107
 
33
-
145
 
95
 
Increase
Foreign government
Matrix pricing
 
Credit spreads (4)
 
48
-
48
 
48
 
4
-
72
 
32
 
Decrease
 
Market pricing
 
Quoted prices (5)
 
1
-
163
 
81
 
64
-
156
 
100
 
Increase
 
Consensus pricing
 
Offered quotes (5)
 
66
-
122
 
108
 
84
-
156
 
107
 
Increase
RMBS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
45
-
413
 
225
 
(136)
-
3,609
 
288
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
22
-
120
 
95
 
10
-
109
 
98
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
1
-
116
 
93
 
69
-
101
 
93
 
Increase (6)
CMBS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 



 

 
215
-
2,025
 
409
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
5
-
112
 
101
 
70
-
104
 
97
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
100
-
100
 
100
 
90
-
101
 
95
 
Increase (6)
ABS
Matrix pricing and discounted cash flow
 
Credit spreads (4)
 
31
-
1,878
 
152
 
30
-
1,878
 
145
 
Decrease (6)
 
Market pricing
 
Quoted prices (5)
 
-
110
 
100
 
-
110
 
101
 
Increase (6)
 
Consensus pricing
 
Offered quotes (5)
 
100
-
100
 
100
 
56
-
106
 
98
 
Increase (6)
Derivatives
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
Interest rate
Present value techniques
 
Swap yield (7)
 
324
-
351
 
 
 
248
-
450
 
 
 
Increase (12)
Foreign currency exchange rate
Present value techniques
 
Swap yield (7)
 
(12)
-
1,012
 
 
 
97
-
767
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
43%
-
55%
 
 
 
38%
-
47%
 
 
 
 
Credit
Present value techniques
 
Credit spreads (9)
 
98
-
101
 
 
 
98
-
101
 
 
 
Decrease (9)
 
Consensus pricing
 
Offered quotes (10)
 
 

 
 
 
 
 
 
 
 
 
 
 
Equity market
Present value techniques or option pricing models
 
Volatility (11)
 
14%
-
28%
 
 
 
13%
-
28%
 
 
 
Increase (12)
 
 
 
 
Correlation (8)
 
65%
-
65%
 
 
 
60%
-
60%
 
 
 
 
Embedded derivatives
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct and assumed guaranteed minimum benefits
Option pricing techniques
 
Mortality rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ages 0 - 40
 
0%
-
0.28%
 
 
 
0%
-
0.14%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 41 - 60
 
0.04%
-
0.88%
 
 
 
0.04%
-
0.88%
 
 
 
Decrease (13)
 
 
 
 
 
Ages 61 - 115
 
0.26%
-
100%
 
 
 
0.26%
-
100%
 
 
 
Decrease (13)
 
 
 
 
Lapse rates:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Durations 1 - 10
 
0.50%
-
100%
 
 
 
0.50%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 11 - 20
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
 
Durations 21 - 116
 
2%
-
100%
 
 
 
2%
-
100%
 
 
 
Decrease (14)
 
 
 
 
Utilization rates
 
20%
-
50%
 
 
 
20%
-
50%
 
 
 
Increase (15)
 
 
 
 
Withdrawal rates
 
0%
-
20%
 
 
 
0%
-
40%
 
 
 
(16)
 
 
 
 
Long-term equity volatilities
 
7.30%
-
33%
 
 
 
9.14%
-
40%
 
 
 
Increase (17)
 
 
 
 
Nonperformance risk spread
 
(0.16)%
-
0.77%
 
 
 
(1.08)%
-
0.83%
 
 
 
Decrease (18)
______________

(1)
The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
(2)
The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
(3)
Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
(4)
Range and weighted average are presented in basis points.
(5)
Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
(6)
Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
(7)
Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(8)
Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
(9)
Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
(10)
At both September 30, 2014 and December 31, 2013, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
(11)
Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
(12)
Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
(13)
Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(14)
Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(15)
The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(16)
The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
(17)
Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
(18)
Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Three Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
7,369

 
$
6,612

 
$
1,672

 
$
320

 
$
3,945

 
$
595

 
$
3,786

 
$
35

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
2

 
7

 
4

 

 
11

 
2

 
1

 

Net investment gains (losses)
 
(1
)
 
(5
)
 

 

 

 
(13
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
14

 
(179
)
 
(32
)
 

 
28

 
9

 
(5
)
 
(1
)
Purchases (3)
 
645

 
449

 
114

 

 
708

 
58

 
1,164

 

Sales (3)
 
(198
)
 
(145
)
 
(29
)
 

 
(340
)
 
(64
)
 
(177
)
 
(7
)
Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
10

 
124

 
167

 

 

 
62

 
74

 

Transfers out of Level 3 (4)
 
(501
)
 
(630
)
 
(618
)
 
(320
)
 
(346
)
 
(15
)
 
(1,564
)
 
(23
)
Balance, end of period
 
$
7,340

 
$
6,233

 
$
1,278

 
$

 
$
4,006

 
$
634

 
$
3,279

 
$
4

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
2

 
$
7

 
$
4

 
$

 
$
10

 
$

 
$
1

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$
(13
)
 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Three Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
186

 
$
263

 
$
20

 
$
109

 
$
571

 
$
11

 
$
246

 
$
367

 
$

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
(4
)
 
(22
)
 

 
1

 
4

 

Net investment gains (losses)
 

 
2

 

 

 

 

 

 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
(37
)
 
(5
)
 

 

 

 

 

 

 

Purchases (3)
 
3

 

 
3

 

 
169

 

 
114

 
3

 

Sales (3)
 
(10
)
 
(13
)
 
(15
)
 
(6
)
 
(288
)
 

 
(131
)
 
(63
)
 

Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 
(13
)
 

Transfers into Level 3 (4)
 
1

 

 

 

 
89

 
1

 

 

 

Transfers out of Level 3 (4)
 
(42
)
 

 

 

 
(31
)
 

 
(75
)
 

 

Balance, end of period
 
$
101

 
$
247

 
$
8

 
$
99

 
$
488

 
$
12

 
$
155

 
$
298

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$
(16
)
 
$

 
$
1

 
$
4

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Three Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
36

 
$
(3
)
 
$
17

 
$
(395
)
 
$
1,020


$
1,691

 
$
(15
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
30

 
(1
)
Net derivative gains (losses)
 
(9
)
 
(68
)
 
(8
)
 
50

 
(58
)
 

 

Policyholder benefits and claims
 

 

 

 
(3
)
 
32

 

 

OCI
 
20

 
2

 

 
2

 
102

 

 

Purchases (3)
 

 

 

 

 

 
117

 

Sales (3)
 

 

 

 

 

 
(129
)
 

Issuances (3)
 
(2
)
 

 
(1
)
 

 

 
1

 

Settlements (3)
 
2

 
15

 

 

 
(231
)
 

 
1

Transfers into Level 3 (4)
 

 

 

 

 

 
219

 

Transfers out of Level 3 (4)
 

 

 

 

 

 
(38
)
 

Balance, end of period
 
$
47

 
$
(54
)
 
$
8

 
$
(346
)
 
$
865

 
$
1,891

 
$
(15
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$
(1
)
Net derivative gains (losses)
 
$
1

 
$
(52
)
 
$
(8
)
 
$
50

 
$
(65
)
 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
(3
)
 
$
31

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Three Months Ended September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
5,918

 
$
6,008

 
$
1,971

 
$
82

 
$
2,735

 
$
1,050

 
$
3,758

 
$
41

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
3

 
5

 
(6
)
 

 
9

 
4

 
3

 

Net investment gains (losses)
 
4

 
(14
)
 
2

 

 
1

 
(1
)
 
5

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
(32
)
 
71

 
(42
)
 

 
(16
)
 
22

 
(4
)
 

Purchases (3)
 
297

 
684

 
209

 

 
563

 
305

 
636

 

Sales (3)
 
(249
)
 
(273
)
 
(61
)
 
(2
)
 
(138
)
 
(71
)
 
(309
)
 
(1
)
Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
117

 
173

 
68

 

 

 

 

 

Transfers out of Level 3 (4)
 
(172
)
 
(390
)
 
(78
)
 
(15
)
 
(136
)
 
(133
)
 
(26
)
 
(24
)
Balance, end of period
 
$
5,886

 
$
6,264

 
$
2,063

 
$
65

 
$
3,018

 
$
1,176

 
$
4,063

 
$
16

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
2

 
$
5

 
$
(6
)
 
$

 
$
9

 
$
4

 
$
3

 
$

Net investment gains (losses)
 
$

 
$
(3
)
 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans - FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Three Months Ended September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
183

 
$
408

 
$
11

 
$
46

 
$
593

 
$

 
$
344

 
$
150

 
$

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
1

 
(43
)
 

 
3

 
(2
)
 

Net investment gains (losses)
 
1

 
(4
)
 

 

 

 

 
(2
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
6

 
11

 

 

 

 

 
7

 

 

Purchases (3)
 
6

 
52

 
6

 

 
308

 

 
106

 
67

 

Sales (3)
 
(11
)
 
(42
)
 
(1
)
 

 
(232
)
 

 
(266
)
 

 

Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 
(3
)
 

Transfers into Level 3 (4)
 
1

 

 

 

 

 

 

 

 

Transfers out of Level 3 (4)
 
(1
)
 
(20
)
 
(5
)
 

 
(20
)
 

 

 

 

Balance, end of period
 
$
185

 
$
405

 
$
11

 
$
47

 
$
606

 
$

 
$
192

 
$
212

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
1

 
$
(1
)
 
$

 
$
2

 
$
(2
)
 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Three Months Ended September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
98

 
$
6

 
$
25

 
$
(171
)
 
$
(678
)
 
$
1,225

 
$
(31
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
4

 

Net derivative gains (losses)
 
5

 
3

 
3

 
(85
)
 
888

 

 

Policyholder benefits and claims
 

 

 

 
5

 
(30
)
 

 

OCI
 
(11
)
 

 
(1
)
 

 
(16
)
 

 

Purchases (3)
 

 

 

 

 

 
106

 

Sales (3)
 

 

 

 

 

 
(84
)
 

Issuances (3)
 

 

 

 

 

 
51

 

Settlements (3)
 
(47
)
 
1

 
4

 

 
(217
)
 
(2
)
 
5

Transfers into Level 3 (4)
 

 

 

 

 

 
162

 

Transfers out of Level 3 (4)
 

 
(1
)
 

 

 

 
(45
)
 

Balance, end of period
 
$
45

 
$
9

 
$
31

 
$
(251
)
 
$
(53
)
 
$
1,417

 
$
(26
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$
5

 
$
6

 
$
3

 
$
(86
)
 
$
882

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
6

 
$
(29
)
 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Nine Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
7,148

 
$
6,704

 
$
2,235

 
$
62

 
$
2,957

 
$
972

 
$
4,210

 
$
10

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
7

 
16

 
106

 

 
34

 
2

 
6

 

Net investment gains (losses)
 
(6
)
 
(8
)
 
(4
)
 

 
8

 
(14
)
 
(39
)
 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
276

 
277

 
(104
)
 

 
96

 
(21
)
 
56

 

Purchases (3)
 
1,213

 
893

 
265

 

 
1,278

 
133

 
2,369

 

Sales (3)
 
(746
)
 
(516
)
 
(160
)
 

 
(443
)
 
(270
)
 
(793
)
 

Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
261

 
281

 
189

 

 
146

 
73

 
37

 
4

Transfers out of Level 3 (4)
 
(813
)
 
(1,414
)
 
(1,249
)
 
(62
)
 
(70
)
 
(241
)
 
(2,567
)
 
(10
)
Balance, end of period
 
$
7,340

 
$
6,233

 
$
1,278

 
$

 
$
4,006

 
$
634

 
$
3,279

 
$
4

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
4

 
$
15

 
$
7

 
$

 
$
34

 
$
(1
)
 
$
2

 
$

Net investment gains (losses)
 
$
(7
)
 
$
(2
)
 
$

 
$

 
$
(1
)
 
$
(13
)
 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
 
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Nine Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
177

 
$
395

 
$
12

 
$
29

 
$
603

 
$

 
$
254

 
$
338

 
$

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
7

 
6

 

 
3

 
15

 

Net investment gains (losses)
 
13

 
4

 

 

 

 

 
(2
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 
(78
)
 
6

 

 

 

 

 
(1
)
 

 

Purchases (3)
 
28

 

 
8

 

 
290

 

 
126

 
49

 

Sales (3)
 
(40
)
 
(58
)
 
(7
)
 
(6
)
 
(449
)
 
(2
)
 
(205
)
 
(78
)
 

Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 
(26
)
 

Transfers into Level 3 (4)
 
1

 

 

 
69

 
60

 
14

 

 

 

Transfers out of Level 3 (4)
 

 
(100
)
 
(5
)
 

 
(22
)
 

 
(20
)
 

 

Balance, end of period
 
$
101

 
$
247

 
$
8

 
$
99

 
$
488

 
$
12

 
$
155

 
$
298

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
11

 
$

 
$

 
$
1

 
$
15

 
$

Net investment gains (losses)
 
$
(2
)
 
$
(3
)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Nine Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
13

 
$
(11
)
 
$
29

 
$
(317
)
 
$
1,258

 
$
1,465

 
$
(28
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
99

 
(1
)
Net derivative gains (losses)
 
16

 
(59
)
 
(17
)
 
(39
)
 
102

 

 

Policyholder benefits and claims
 

 

 

 
4

 
55

 

 

OCI
 
69

 
2

 

 
2

 
78

 

 

Purchases (3)
 

 

 

 
4

 

 
510

 

Sales (3)
 

 

 

 

 

 
(337
)
 

Issuances (3)
 
(2
)
 

 
(4
)
 

 

 
82

 

Settlements (3)
 
(49
)
 
14

 

 

 
(628
)
 
(28
)
 
14

Transfers into Level 3 (4)
 

 

 

 

 

 
147

 

Transfers out of Level 3 (4)
 

 

 

 

 

 
(47
)
 

Balance, end of period
 
$
47

 
$
(54
)
 
$
8

 
$
(346
)
 
$
865

 
$
1,891

 
$
(15
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$
(1
)
Net derivative gains (losses)
 
$
1

 
$
(45
)
 
$
(15
)
 
$
(38
)
 
$
103

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
4

 
$
55

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Fixed Maturity Securities
 
 
U.S.
Corporate
 
Foreign
Corporate
 
Foreign
Government
 
U.S.
Treasury
and Agency
 
RMBS
 
CMBS
 
ABS
 
State and
Political
Subdivision
 
 
(In millions)
Nine Months Ended September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
7,433

 
$
6,208

 
$
1,814

 
$
71

 
$
2,037

 
$
1,147

 
$
3,656

 
$
54

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
10

 
11

 
3

 

 
20

 
2

 
12

 

Net investment gains (losses)
 
(27
)
 
(34
)
 
8

 

 
4

 
(2
)
 
5

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

OCI
 
(38
)
 
(97
)
 
(104
)
 
(2
)
 
108

 
(28
)
 
(60
)
 
(1
)
Purchases (3)
 
824

 
1,364

 
551

 

 
1,155

 
549

 
1,510

 
1

Sales (3)
 
(907
)
 
(714
)
 
(105
)
 
(4
)
 
(242
)
 
(339
)
 
(651
)
 
(6
)
Issuances (3)
 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

Transfers into Level 3 (4)
 
324

 
254

 
91

 

 
12

 
113

 

 

Transfers out of Level 3 (4)
 
(1,733
)
 
(728
)
 
(195
)
 

 
(76
)
 
(266
)
 
(409
)
 
(32
)
Balance, end of period
 
$
5,886

 
$
6,264

 
$
2,063

 
$
65

 
$
3,018

 
$
1,176

 
$
4,063

 
$
16

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$
9

 
$
10

 
$
3

 
$

 
$
26

 
$
2

 
$
10

 
$

Net investment gains (losses)
 
$
(34
)
 
$
(3
)
 
$

 
$

 
$
(1
)
 
$

 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Equity Securities
 
FVO and Trading Securities
 
 
 
 
 
Mortgage Loans
 
 
Common
Stock
 
Non-
redeemable
Preferred
Stock
 
Actively
Traded
Securities
 
FVO
General
Account
Securities
 
FVO
Contractholder-
directed
Unit-linked
Investments
 
FVO Securities
Held by CSEs
 
Short-term
Investments
 
Residential
Mortgage
Loans -
FVO
 
Mortgage
Loans Held-
for-sale
 
 
(In millions)
Nine Months Ended September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
190

 
$
419

 
$
6

 
$
32

 
$
937

 
$

 
$
429

 
$

 
$
49

Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 
6

 
(12
)
 

 
3

 
(2
)
 

Net investment gains (losses)
 
2

 
(28
)
 

 

 

 

 
(24
)
 

 

Net derivative gains (losses)
 

 

 

 

 

 

 

 

 

Policyholder benefits and claims
 

 

 

 

 

 

 

 

 

OCI
 

 
77

 

 

 

 

 
15

 

 

Purchases (3)
 
11

 
55

 
8

 

 
348

 

 
189

 
214

 

Sales (3)
 
(15
)
 
(118
)
 

 
(5
)
 
(430
)
 

 
(414
)
 

 
(45
)
Issuances (3)
 

 

 

 

 

 

 

 

 

Settlements (3)
 

 

 

 

 

 

 

 

 
(4
)
Transfers into Level 3 (4)
 
1

 

 

 
14

 
57

 

 

 

 

Transfers out of Level 3 (4)
 
(4
)
 

 
(3
)
 

 
(294
)
 

 
(6
)
 

 

Balance, end of period
 
$
185

 
$
405

 
$
11

 
$
47

 
$
606

 
$

 
$
192

 
$
212

 
$

Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$
6

 
$
(5
)
 
$

 
$
2

 
$
(2
)
 
$

Net investment gains (losses)
 
$
(1
)
 
$
(17
)
 
$

 
$

 
$

 
$

 
$
(1
)
 
$

 
$

Net derivative gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Net Derivatives (6)
 
 
 
 
 
 
 
 
Interest
Rate
 
Foreign
Currency
Exchange
Rate
 
Credit
 
Equity
Market
 
Net
Embedded
Derivatives (7)
 
Separate
Account
Assets (8)
 
Long-term
Debt of
CSEs — FVO
 
 
(In millions)
Nine Months Ended September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 
$
177

 
$
37

 
$
43

 
$
128

 
$
(3,162
)
 
$
1,205

 
$
(44
)
Total realized/unrealized gains (losses) included in:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss): (1), (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 

 

 

 

 

 

 

Net investment gains (losses)
 

 

 

 

 

 
25

 
(1
)
Net derivative gains (losses)
 
(23
)
 
(30
)
 
(12
)
 
(390
)
 
3,609

 

 

Policyholder benefits and claims
 

 

 

 
15

 
(110
)
 

 

OCI
 
(83
)
 

 

 
(1
)
 
193

 

 

Purchases (3)
 

 

 

 
4

 

 
249

 

Sales (3)
 

 

 

 

 

 
(223
)
 

Issuances (3)
 

 

 

 

 

 
71

 

Settlements (3)
 
(27
)
 
2

 

 
(7
)
 
(583
)
 

 
19

Transfers into Level 3 (4)
 

 

 

 

 

 
161

 

Transfers out of Level 3 (4)
 
1

 

 

 

 

 
(71
)
 

Balance, end of period
 
$
45

 
$
9

 
$
31

 
$
(251
)
 
$
(53
)
 
$
1,417

 
$
(26
)
Changes in unrealized gains (losses) included in net income (loss): (5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net investment income
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Net investment gains (losses)
 
$

 
$

 
$

 
$

 
$

 
$

 
$
(1
)
Net derivative gains (losses)
 
$
(14
)
 
$
(28
)
 
$
(11
)
 
$
(390
)
 
$
3,589

 
$

 
$

Policyholder benefits and claims
 
$

 
$

 
$

 
$
15

 
$
(106
)
 
$

 
$

__________________
(1)
Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities and mortgage loans held-for-sale are included in net investment gains (losses), while changes in estimated fair value of mortgage loans - FVO are included in net investment income. Lapses associated with net embedded derivatives are included in net derivative gains (losses).
(2)
Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
(3)
Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.
(4)
Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
(5)
Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods.
(6)
Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
(7)
Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
(8)
Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses).
Fair Value Option
The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.
 
 
Residential Mortgage
Loans — FVO (1)
 
Certain Assets
and Liabilities
of CSEs — FVO (2)
 
 
September 30, 2014
 
December 31, 2013
 
September 30, 2014
 
December 31, 2013
 
 
(In millions)
Assets
 
 
 
 
 
 
 
 
Unpaid principal balance
 
$
438

 
$
508

 
$
257

 
$
1,528

Difference between estimated fair value and unpaid principal balance
 
(140
)
 
(170
)
 
56

 
70

Carrying value at estimated fair value
 
$
298

 
$
338

 
$
313

 
$
1,598

Loans in non-accrual status
 
$
109

 
$

 
$

 
$

Loans more than 90 days past due
 
$
74

 
$
81

 
$

 
$

Loans in non-accrual status or more than 90 days past due, or both — difference between aggregate estimated fair value and unpaid principal balance
 
$
(82
)
 
$
(82
)
 
$

 
$

Liabilities
 
 
 
 
 
 
 
 
Contractual principal balance
 
 
 
 
 
$
195

 
$
1,445

Difference between estimated fair value and contractual principal balance
 
 
 
 
 
(9
)
 
10

Carrying value at estimated fair value
 
 
 
 
 
$
186

 
$
1,455

__________________
(1)
Interest income, changes in estimated fair value and gains or losses on sales are recognized in net investment income. Changes in estimated fair value for these loans were due to the following:
 
 
Three Months 
 Ended 
 September 30,
 
Nine Months 
 Ended 
 September 30,
 
 
2014
 
2013
 
2014
 
2013
 
 
(In millions)
Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality
 
$
3

 
$

 
$
8

 
$

Other changes in estimated fair value
 
1

 
(2
)
 
5

 
(2
)
Total gains (losses) recognized in net investment income
 
$
4

 
$
(2
)
 
$
13

 
$
(2
)
(2)
These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.
Nonrecurring Fair Value Measurements
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
 
At September 30,
 
Three Months 
 Ended 
 September 30,
 
Nine Months 
 Ended 
 September 30,
 
2014
 
2013
 
2014
 
2013
 
2014
 
2013
 
Carrying Value After Measurement
 
Gains (Losses)
 
(In millions)
Mortgage loans, net (1)
$
106

 
$
232

 
$
4

 
$
(4
)
 
$
3

 
$
13

Other limited partnership interests (2)
$
92

 
$
70

 
$
(14
)
 
$

 
$
(51
)
 
$
(39
)
Real estate joint ventures (3)
$

 
$
3

 
$
(1
)
 
$

 
$
(1
)
 
$
(2
)
__________________
(1)
Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.
(2)
For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both September 30, 2014 and 2013 were not significant.
(3)
For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include several real estate funds that typically invest primarily in commercial real estate and mezzanine debt. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next one to 10 years. Unfunded commitments for these investments at both September 30, 2014 and 2013 were not significant.
Fair Value of Financial Instruments Carried at Other Than Fair Value
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
 
September 30, 2014
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
 
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
57,427

 
$

 
$

 
$
60,226

 
$
60,226

Policy loans
$
11,756

 
$

 
$
1,684

 
$
11,744

 
$
13,428

Real estate joint ventures
$
83

 
$

 
$

 
$
162

 
$
162

Other limited partnership interests
$
774

 
$

 
$

 
$
1,047

 
$
1,047

Other invested assets
$
603

 
$
202

 
$
74

 
$
327

 
$
603

Premiums, reinsurance and other receivables
$
3,726

 
$

 
$
1,380

 
$
2,402

 
$
3,782

Other assets
$
710

 
$

 
$
626

 
$
74

 
$
700

Liabilities
 
 
 
 
 
 
 
 
 
PABs
$
139,278

 
$

 
$

 
$
145,619

 
$
145,619

Long-term debt
$
16,174

 
$

 
$
18,042

 
$

 
$
18,042

Collateral financing arrangements
$
4,196

 
$

 
$

 
$
3,993

 
$
3,993

Junior subordinated debt securities
$
3,193

 
$

 
$
4,176

 
$

 
$
4,176

Other liabilities
$
6,274

 
$

 
$
4,981

 
$
1,294

 
$
6,275

Separate account liabilities
$
119,328

 
$

 
$
119,328

 
$

 
$
119,328

 
December 31, 2013
 
 
 
Fair Value Hierarchy
 
 
 
Carrying
Value
 
Level 1
 
Level 2
 
Level 3
 
Total
Estimated
Fair Value
 
(In millions)
Assets
 
 
 
 
 
 
 
 
 
Mortgage loans
$
55,770

 
$

 
$

 
$
57,924

 
$
57,924

Policy loans
$
11,764

 
$

 
$
1,694

 
$
11,512

 
$
13,206

Real estate joint ventures
$
102

 
$

 
$

 
$
169

 
$
169

Other limited partnership interests
$
950

 
$

 
$

 
$
1,109

 
$
1,109

Other invested assets
$
844

 
$
322

 
$
163

 
$
359

 
$
844

Premiums, reinsurance and other receivables
$
3,116

 
$

 
$
728

 
$
2,382

 
$
3,110

Other assets
$
324

 
$

 
$
210

 
$
142

 
$
352

Liabilities
 
 
 
 
 
 
 
 
 
PABs
$
139,735

 
$

 
$

 
$
144,631

 
$
144,631

Long-term debt
$
17,170

 
$

 
$
18,564

 
$

 
$
18,564

Collateral financing arrangements
$
4,196

 
$

 
$

 
$
3,984

 
$
3,984

Junior subordinated debt securities
$
3,193

 
$

 
$
3,789

 
$

 
$
3,789

Other liabilities
$
2,239

 
$

 
$
948

 
$
1,292

 
$
2,240

Separate account liabilities
$
117,562

 
$

 
$
117,562

 
$

 
$
117,562